Phase II study of estramustine, oral etoposide, and vinorelbine in hormone-refractory prostate cancer

Marco Colleoni, C. Graiff, G. Vicario, P. Nelli, G. Sgarbossa, F. Pancheri, P. Manente

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Phase II study of estramustine, oral etoposide, and vinorelbine in hormone-refractory prostate cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences